Salem Capital Management Inc Eli Lilly & CO Transaction History

Salem Capital Management Inc

$126 Million
Q3 2022

A detailed history of Salem Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Salem Capital Management Inc holds 2,897 shares of LLY stock, worth $2.17 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

2,897

Previous 2,897 -0.0%

Holding current value

$2.17 Million

Previous $939,000 0.21%

% of portfolio

0.74%

Previous 0.68%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$278.73 - $327.27 $110,655 - $129,926	-397 Reduced 12.05%	2,897 $939,000
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $22,485 - $27,904	100 Added 3.13%	3,294 $910,000
Q3 2021 Oct 12, 2021	SELL	$221.6 - $272.71 $66,480 - $81,813	-300 Reduced 8.59%	3,194 $738,000
Q2 2021 Jul 13, 2021	SELL	$180.55 - $233.54 $144,440 - $186,832	-800 Reduced 18.63%	3,494 $802,000
Q1 2021 Apr 15, 2021	SELL	$164.32 - $212.72 $8,216 - $10,636	-50 Reduced 1.15%	4,294 $802,000
Q3 2020 Oct 13, 2020	SELL	$146.22 - $169.13 $73,110 - $84,565	-500 Reduced 10.32%	4,344 $643,000
Q3 2019 Oct 07, 2019	SELL	$106.79 - $116.16 $21,037 - $22,883	-197 Reduced 3.91%	4,844 $542,000
Q2 2019 Jul 09, 2019	SELL	$110.79 - $129.32 $57,278 - $66,858	-517 Reduced 9.3%	5,041 $558,000
Q1 2019 Apr 15, 2019	BUY	$111.31 - $131.02 $44,190 - $52,014	397 Added 7.69%	5,558 $721,000
Q4 2018 Jan 08, 2019	SELL	$105.9 - $118.64 $24,568 - $27,524	-232 Reduced 4.3%	5,161 $597,000
Q3 2018 Oct 09, 2018	SELL	$85.86 - $107.31 $14,939 - $18,671	-174 Reduced 3.13%	5,393 $579,000
Q4 2017 Jan 16, 2018	SELL	$81.94 - $87.89 $40,970 - $43,945	-500 Reduced 8.24%	5,567 $470,000
Q3 2017 Oct 10, 2017	BUY	$77.07 - $85.54 $467,583 - $518,971	6,067	6,067 $519,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Capital Management Inc with notifications on news.

Account

Salem Capital Management Inc Eli Lilly & CO Transaction History